The Cooper Companies stock (US2166481027): Piper Sandler trims price target ahead of next earnings update

On the US Nasdaq, shares of The Cooper Companies traded around USD 61 in recent sessions as Wall Street digested a new analyst adjustment from Piper Sandler dated 06/01/2026, which cut its price target on the stock to USD 86 from USD 94 while reiterating an Overweight stance, according to a note cited by The Fly via TipRanks as of 06/01/2026.

The move keeps the United States-based medical device group in focus on its home market, where it remains listed under ticker COO on Nasdaq, and comes as investors position for the next earnings release following a period in which its market capitalization stood at about USD 11.94 billion as of 05/29/2026, according to Stock Analysis as of 05/29/2026.

As of: 02/02/2026

By the editorial team - specialized in equity coverage.

The Cooper Companies: core business model

The Cooper Companies generates most of its revenue by supplying specialty contact lenses under CooperVision and a portfolio of fertility and women's health products and services through CooperSurgical to eye-care professionals and healthcare providers worldwide.

Latest quarterly results for The Cooper Companies at a glance

For its most recently reported quarter, The Cooper Companies posted results that provide the fundamental backdrop for the latest analyst commentary, with investors monitoring how its contact lens and women's health franchises are performing in the United States and key international regions; while detailed figures for the upcoming quarter are still pending, Wall Street consensus has centered on mid-single-digit percentage revenue growth and earnings per share in the low single-digit USD range, according to aggregated projections referenced by Zacks on 05/30/2026.

The Zacks article on 05/30/2026 highlighted that analysts were watching key metrics such as unit growth in silicone hydrogel lenses and margins in the fertility business, framing expectations for the next update after earlier quarterly reports showed that The Cooper Companies had been managing cost pressures while investing in product development and market expansion, according to the same Zacks analysis as of 05/30/2026.

Conclusion

The latest Piper Sandler move to lower its price target for The Cooper Companies to USD 86 from USD 94 while keeping an Overweight rating gives investors an updated valuation signal to consider alongside the current share price level on Nasdaq.

With Wall Street expectations for the next quarterly report centering on ongoing growth in contact lenses and women's health, the coming earnings release will help indicate whether the company can underpin analyst assumptions and potentially influence future target price revisions.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.